
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15293567
[patent_doc_number] => 20190389919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => Recombinant Dermatophagoides farinae Type 1 Allergen Protein and Its Preparation Method and Application
[patent_app_type] => utility
[patent_app_number] => 16/456357
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16456357
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/456357 | Recombinant | Jun 27, 2019 | Issued |
Array
(
[id] => 15083563
[patent_doc_number] => 20190336592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => OMPA AND ASP14 IN VACCINE COMPOSITIONS AND AS DIAGNOSTIC TARGETS
[patent_app_type] => utility
[patent_app_number] => 16/454797
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454797 | OmpA and Asp14 in vaccine compositions and as diagnostic targets | Jun 26, 2019 | Issued |
Array
(
[id] => 14963673
[patent_doc_number] => 20190309315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => GENETICALLY ENGINEERED CANDIDA UTILIS CAPABLE OF DEGRADING AND UTILIZING KITCHEN WASTE AND CONSTRUCTION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/449858
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/449858 | Genetically engineered | Jun 23, 2019 | Issued |
Array
(
[id] => 16769764
[patent_doc_number] => 10980847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Compositions and methods for detecting and treating brain injury associated fatigue and altered cognition (BIAFAC)
[patent_app_type] => utility
[patent_app_number] => 16/449047
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 17446
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/449047 | Compositions and methods for detecting and treating brain injury associated fatigue and altered cognition (BIAFAC) | Jun 20, 2019 | Issued |
Array
(
[id] => 15025711
[patent_doc_number] => 20190323860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => COMPOSITIONS FOR THE INHIBITION OF GIARDIA LAMBLIA
[patent_app_type] => utility
[patent_app_number] => 16/445569
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445569
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445569 | Compositions for the inhibition of | Jun 18, 2019 | Issued |
Array
(
[id] => 15848151
[patent_doc_number] => 10639336
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-05-05
[patent_title] => Use of a probiotic composition for preventing stroke and ameliorating the severity of stroke
[patent_app_type] => utility
[patent_app_number] => 16/435944
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3404
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16435944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/435944 | Use of a probiotic composition for preventing stroke and ameliorating the severity of stroke | Jun 9, 2019 | Issued |
Array
(
[id] => 16444893
[patent_doc_number] => 10836805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Chemoenzymatic glycoengineering of antibodies and FC fragments thereof
[patent_app_type] => utility
[patent_app_number] => 16/431907
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 43
[patent_no_of_words] => 14458
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431907
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/431907 | Chemoenzymatic glycoengineering of antibodies and FC fragments thereof | Jun 4, 2019 | Issued |
Array
(
[id] => 14868011
[patent_doc_number] => 20190284247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => NOVEL RHTB PROTEIN VARIANTS AND THE METHOD OF PRODUCING O-PHOSPHOSERINE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/423986
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423986 | RHTB protein variants and the method of producing O-phosphoserine using the same | May 27, 2019 | Issued |
Array
(
[id] => 15290829
[patent_doc_number] => 20190388550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => Compositions and Methods for Oral Delivery of Therapeutic Cargo
[patent_app_type] => utility
[patent_app_number] => 16/414671
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16414671
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/414671 | Compositions and methods for oral delivery of therapeutic cargo | May 15, 2019 | Issued |
Array
(
[id] => 15290769
[patent_doc_number] => 20190388520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => Compositions and Methods for Oral Delivery of Therapeutic Cargo
[patent_app_type] => utility
[patent_app_number] => 16/414686
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16414686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/414686 | Compositions and methods for oral delivery of therapeutic cargo | May 15, 2019 | Issued |
Array
(
[id] => 16428295
[patent_doc_number] => 10828356
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-11-10
[patent_title] => Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
[patent_app_type] => utility
[patent_app_number] => 16/410627
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 11
[patent_no_of_words] => 19289
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16410627
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/410627 | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity | May 12, 2019 | Issued |
Array
(
[id] => 15293583
[patent_doc_number] => 20190389927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => CD147 AS RECEPTOR FOR PILUS-MEDIATED ADHESION OF MENINGOCOCCI TO VASCULAR ENDOTHELIA
[patent_app_type] => utility
[patent_app_number] => 16/397196
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397196
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/397196 | CD147 AS RECEPTOR FOR PILUS-MEDIATED ADHESION OF MENINGOCOCCI TO VASCULAR ENDOTHELIA | Apr 28, 2019 | Abandoned |
Array
(
[id] => 15267443
[patent_doc_number] => 20190382455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => FUSION MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/393410
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393410
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/393410 | Fusion molecules | Apr 23, 2019 | Issued |
Array
(
[id] => 17466756
[patent_doc_number] => 11273213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-15
[patent_title] => Chimeric vaccine antigens for anaplasmosis
[patent_app_type] => utility
[patent_app_number] => 17/048296
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 28
[patent_no_of_words] => 14909
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048296 | Chimeric vaccine antigens for anaplasmosis | Apr 16, 2019 | Issued |
Array
(
[id] => 15814007
[patent_doc_number] => 10632160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Probiotic composition for preventing, improving or alleviating pancreatic cancer and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/361599
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 31
[patent_no_of_words] => 5715
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361599
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361599 | Probiotic composition for preventing, improving or alleviating pancreatic cancer and application thereof | Mar 21, 2019 | Issued |
Array
(
[id] => 14775099
[patent_doc_number] => 20190262447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => Vaccine
[patent_app_type] => utility
[patent_app_number] => 16/281567
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281567
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/281567 | Vaccine | Feb 20, 2019 | Issued |
Array
(
[id] => 14406943
[patent_doc_number] => 20190169315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => Antibodies Targeted to Fungal Cell Wall Polysaccharides
[patent_app_type] => utility
[patent_app_number] => 16/267430
[patent_app_country] => US
[patent_app_date] => 2019-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16267430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/267430 | Antibodies targeted to fungal cell wall polysaccharides | Feb 4, 2019 | Issued |
Array
(
[id] => 17103226
[patent_doc_number] => 11123417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Multivalent pneumococcal polysaccharide-protein conjugate composition
[patent_app_type] => utility
[patent_app_number] => 16/966584
[patent_app_country] => US
[patent_app_date] => 2019-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17192
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966584
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966584 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Feb 3, 2019 | Issued |
Array
(
[id] => 17161781
[patent_doc_number] => 11147864
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Multivalent pneumococcal polysaccharide-protein conjugate composition
[patent_app_type] => utility
[patent_app_number] => 16/966552
[patent_app_country] => US
[patent_app_date] => 2019-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18073
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966552
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966552 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Feb 3, 2019 | Issued |
Array
(
[id] => 16276837
[patent_doc_number] => 10759851
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Synthetic antibodies to BAX and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/261703
[patent_app_country] => US
[patent_app_date] => 2019-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 10470
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16261703
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/261703 | Synthetic antibodies to BAX and uses thereof | Jan 29, 2019 | Issued |